Utilizing benzodiazepines in clinical practice: an evidence-based discussion.
D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D001569:Benzodiazepines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000139:chemically induced; D015928:Cognitive Behavioral Therapy; D004334:Drug Administration Schedule; D006801:Humans; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic; D018079:Receptors, GABA / Q000737:chemistry / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000517:prevention & control; D019966:Substance-Related Disorders / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
D018079:Receptors, GABA; D001569:Benzodiazepines